Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Biolin Scientific AB
AB
Active
Org 5562494293
Hängpilsgatan 7, 426 77
Västra Frölunda
Activities of head offices
·
NACE 7010
Est. 1984 · 41 years old
22 employees
Monitor
Share
Sweden
/
Companies
/
Activities of head offices
/
Biolin Scientific AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
176M
132M
88M
44M
0M
2020: 91M
91M
2020
2021: 107M (+18% vs 2020)
107M
+18%
2021
2022: 118M (+10% vs 2021)
118M
+10%
2022
2023: 141M (+19% vs 2022)
141M
+19%
2023
2024: 136M (-4% vs 2023)
136M
-4%
2024
EBITDA
SEK millions
34M
25M
17M
8M
0M
2020: 19M
19M
2020
2021: 21M (+11% vs 2020)
21M
+11%
2021
2022: 26M (+24% vs 2021)
26M
+24%
2022
2023: 27M (+4% vs 2022)
27M
+4%
2023
2024: 10M (-63% vs 2023)
10M
-63%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
135 519
140 636
118 087
106 935
90 579
Staff expenses
—
—
—
—
—
EBITDA
10 387
27 000
26 019
20 933
19 078
Depreciation & amort.
−7 383
−3 840
−5 294
−5 783
−6 655
EBIT
3 004
23 160
20 725
15 150
12 423
Net financials
669
214
−411
−218
−152
Profit before tax
4 076
23 845
20 775
15 071
12 271
Tax
−753
−4 949
−4 434
−5 109
−764
Net profit
3 323
18 896
16 341
9 962
11 507
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
148 624
142 530
121 915
104 818
108 800
Equity
115 356
112 032
93 137
76 796
66 834
Long-term debt
0
0
0
0
20 527
Short-term debt
32 241
29 468
27 955
27 256
20 939
Total debt
32 241
29 468
27 955
27 256
41 466
Financial ratios
5-year trend
EBITDA margin
7,7 %
This company
15,8 %
Market median
This company
Market median
51% below market
2020
2024
Equity ratio
77,6 %
This company
38,2 %
Market median
This company
Market median
103% above market
2020
2024
Return on equity
2,9 %
This company
18,4 %
Market median
This company
Market median
84% below market
2020
2024
Net profit margin
2,5 %
This company
8,1 %
Market median
This company
Market median
69% below market
2020
2024
Asset turnover
0,91×
This company
1,12×
Market median
This company
Market median
19% below market
2020
2024
Debt / equity
0,29×
This company
0,62×
Market median
This company
Market median
53% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Biolin Scientific AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
